Zohydro ER becomes the first extended release hydrocodone product to be approved by the FDA. Zohydro ER is a product of Zogenix Pharmaceuticals..Read More
Fetzima ER approved by the FDA for the treatment of major depressive disorder in adults…Read More
Breo Ellipta approved by the FDA for long term maintenance of airflow obstruction in patients with COPD…Read More
ZubSolv, sublingual buprenorphine and naloxone tabs approved by the FDA for treatment of opioid addiction in combination with behavioral therapy and counseling…Read More
Gilotrif, tyrosine kinase inhibitor, approved by the FDA for treatment of metastatic non small celll lung cancer…Read More
Khedezla now approved for major depressive disorder…Read More
MIrvaso, brimonidine tartrate, now approved for recurrent rosacea…Read More
Adasuve now approved for agitation associated with schizophrenia or bipolar disorder…Read More
Tafinlar now approved for unresectable or metastatic melanoma…Read More
Mekinist approved for the treatment of unresectable or metastatic melanoma in patents with BRAF V600E or V600K mutations…Read More
